ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,455,028 | +558.0% | 19,232 | +421.6% | 0.07% | +516.7% |
| Q2 2023 | $1,436,934 | -61.6% | 3,687 | -63.3% | 0.01% | -66.7% |
| Q1 2023 | $3,740,702 | -63.3% | 10,040 | -62.7% | 0.04% | -57.6% |
| Q4 2022 | $10,183,708 | +311.6% | 26,882 | +311.5% | 0.08% | +254.2% |
| Q2 2022 | $2,474,000 | +252.4% | 6,533 | +193.4% | 0.02% | +300.0% |
| Q1 2022 | $702,000 | -87.4% | 2,227 | -86.0% | 0.01% | -88.2% |
| Q4 2021 | $5,574,000 | +460.8% | 15,916 | +382.3% | 0.05% | +363.6% |
| Q2 2021 | $994,000 | +258.8% | 3,300 | +57.1% | 0.01% | -35.3% |
| Q1 2020 | $277,000 | -19.0% | 2,100 | -30.0% | 0.02% | +70.0% |
| Q3 2019 | $342,000 | -94.3% | 3,000 | -92.9% | 0.01% | -95.3% |
| Q2 2019 | $6,002,000 | +121.6% | 42,400 | +50.4% | 0.21% | +103.8% |
| Q4 2018 | $2,709,000 | +279.9% | 28,200 | +200.0% | 0.10% | +225.0% |
| Q3 2018 | $713,000 | +1.3% | 9,400 | +10.6% | 0.03% | -15.8% |
| Q2 2018 | $704,000 | -86.8% | 8,500 | -87.2% | 0.04% | -90.5% |
| Q1 2018 | $5,326,000 | +303.8% | 66,209 | +217.0% | 0.40% | +270.4% |
| Q4 2017 | $1,319,000 | – | 20,883 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |